MGMT and glioblastoma: Evidence for this can be found in a previous single-institute retrospective clinical study from our group, in which delivering TMZ in the morning (AM) increased overall survival by six months, compared to evening (PM) treatment, particularly in GBM patients with MGMT-methylated tumors [13].